TNF and rheumatoid arthritis: In the meantime, professional medical societies have also issued differentiated recommendations.<h4>Objectives</h4>The aim was to investigate the RHADAR (RheumaDatenRhePort) registry to check whether JAKi prescriptions recovered thereafter.<h4>Materials and methods</h4>A retrospective analysis of new prescriptions for JAKi, tumor necrosis factor inhibitors (TNFi), and interleukin‐6 receptor inhibitors (IL-6Ri) in patients with rheumatoid arthritis between 1 April 2020, and 30 September 2024.